Latest Strategic Shift News

Page 111 of 113
Southern Cross Gold Consolidated Ltd has completed its acquisition of Southern Cross Gold Ltd, issuing over 125 million shares and announcing key board changes. The move positions the company to advance the high-potential Sunday Creek Gold-Antimony Project amid a strengthened leadership team.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Infinity Lithium updates on regulatory feedback delaying its San José mining licence and pivots to larger European funding opportunities, signaling a strategic shift in project development.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.
Ada Torres
Ada Torres
24 Jan 2025
I Synergy Group Limited has reshaped its board with the resignation of Joshua Hunt, the appointment of Jiayi Yu as Non-Executive Director, and the promotion of Heng Jee Meng to Managing Director, signaling a renewed focus on shareholder value.
Sophie Babbage
Sophie Babbage
24 Jan 2025
Galilee Energy reports a $1.9 million R&D tax refund and terminates its merger with Vintage Energy, while maintaining steady progress at its Glenaras Gas Project and a robust cash position of $4.38 million.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Top Shelf International Holdings Ltd has agreed to sell its Campbellfield production assets to Idyll Wine Co for $8 million, aiming to streamline operations and reduce debt. The deal paves the way for a new co-packing partnership post-sale.
Victor Sage
Victor Sage
24 Jan 2025
IPB Petroleum has appointed a new chairman and is intensifying efforts to secure funding for drilling its key Browse Basin assets, while maintaining a strong cash position and exploring new project opportunities.
Victor Sage
Victor Sage
23 Jan 2025
InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.
Ada Torres
Ada Torres
23 Jan 2025
Universal Biosensors has secured a Vendor Master Purchase Agreement with Chewy and launched its Petrackr veterinary glucose monitoring system on Amazon, positioning itself for significant growth in North America's online pet care market.
Ada Torres
Ada Torres
23 Jan 2025
Tinybeans Group Limited reported a 9% increase in quarterly subscription revenue to US$0.80 million in Q2 FY25, alongside a significant reduction in cash burn and operational expenses following a major restructure.
Sophie Babbage
Sophie Babbage
23 Jan 2025
The Calmer Co. International Limited has reported a remarkable surge in sales and cash receipts for the first half of FY25, exceeding the entire FY24 sales. Alongside a strategic CEO transition and factory upgrade, the company is sharpening its focus on profitable growth and cost control.
Victor Sage
Victor Sage
23 Jan 2025
Next Science reported a 2.9% revenue increase to US$22.8 million in FY24, driven by an 85% surge in XPERIENCE™ sales, while achieving adjusted EBITDA and cashflow positivity in 4Q FY24 amid strategic cost restructuring.
Victor Sage
Victor Sage
23 Jan 2025